Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 2,845-2,856 of 12,112
Other study type icon
RecruitingISRCTN36607067

Pharmacological treatment of psychotic depression

This study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.

In Netherlands
Depression, SchizophreniaOtherOver 18 Years
Countries
Netherlands
Sponsor
University Medical Center Utrecht (UMCU) (The Netherlands)
Condition
Depression, Schizophrenia
Other study type icon
RecruitingNCT07029581

ACP-204 for Schizophrenia

This study is recruiting in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.

Multiple locations, including Irvine
SchizophreniaOtherFrom 55 Years to 84 Years
Countries
United States, France, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN97049967

Effectiveness of lurasidone in schizophrenia

This study is recruiting in the United Kingdom, in Argentina, in Brazil, .... It is testing lurasidone for schizophrenia.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United Kingdom, Argentina, Brazil, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Other study type icon
RecruitingNCT06559306

Treatment With Seltorexant for depression

This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing treatment With Seltorexant for depression.

Multiple locations, including Birmingham
DepressionOtherFrom 18 Years to 74 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Other study type icon
RecruitingISRCTN77277298

Hypericum extract WS® 5570 for depression

This study is recruiting in Germany. It is testing Hypericum extract WS® 5570 for depression.

In Germany
DepressionOtherOver 18 Years
Countries
Germany
Sponsor
Schwabe Pharmaceuticals (Germany)
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.